Cindy Ocran

Cindy Ocran practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Cindy Ocran's NPI, 1356878862, was assigned on May 15, 2017. Cindy Ocran graduated from Renaissance School of Medicine at Stony Brook University in 2017. Cindy Ocran holds California license A172136.

Cindy Ocran's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Cindy Ocran's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. Cindy Ocran is also affiliated with Sharp Memorial Hospital. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Cindy Ocran to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Cindy Ocran practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Cindy Ocran's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Cindy Ocran is board certified in ophthalmology by the American Board of Ophthalmology. Cindy Ocran is licensed in California.

CMS data shows 77 Medicare services from Cindy Ocran across 4 procedure codes in 2024, for 74 Medicare patients. Medicare paid $6,396 for them. Every service was in an office.

CMS counts 74 Medicare patients who saw Cindy Ocran in 2024. The largest group is 65 to 74, with 30 patients. 64% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Cindy Ocran's median patient age at 69, with 69% women.

In 2024, Cindy Ocran wrote 244 Medicare Part D claims for 142 patients. 94% of them were for generic drugs. CMS names the drug for 187 of them, across 3 drugs with 11 or more claims each, at $2,689 in total drug cost. In 2023, CMS named 369 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Cindy Ocran for performance year 2024, reported as part of a group. Cindy Ocran accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Cindy Ocran in 2021. 2021 was the busiest year, with 2. Cindy Ocran's most frequent co-authors are Kimberly P. Cockerham, MD, Rachel Kim Sobel, MD and Kristina Marie Thomas, MD.

CMS Open Payments shows 44 general payments to Cindy Ocran from 7 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $964.

Cindy Ocran graduated from Renaissance School of Medicine at Stony Brook University in 2017.

Cindy Ocran is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.